patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · antibody
infliximab biosimilar
Marketedupdated 2mo agoby Xentria Inc🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 8 approved and 44 investigational indications.
indications
investigational
IBD (Crohn's + UC)Rheumatoid Arthritis
targets
Tumor necrosis factor
all catalysts(6)
approval · 6
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that